ACIP votes to expand recommendation for Pfizer’s RSV vaccine ABRYSVO to include adults aged 50 – 59 at increased risk of disease
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
More than 40 types of Amyloid proteins are discovered till date
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Subscribe To Our Newsletter & Stay Updated